WDFY1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.148800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.047400E-01
Normal-vs-Stage2
9.874800E-01
Normal-vs-Stage3
2.942400E-01
Normal-vs-Stage4
4.473800E-01
Stage1-vs-Stage2
2.551400E-01
Stage1-vs-Stage3
8.557400E-01
Stage1-vs-Stage4
5.494000E-02
Stage2-vs-Stage3
2.845000E-01
Stage2-vs-Stage4
4.799800E-01
Stage3-vs-Stage4
6.706100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.775600E-01
Normal-vs-AfricanAmerican
9.964600E-01
Normal-vs-Asian
9.828600E-01
Caucasian-vs-AfricanAmerican
8.242600E-01
Caucasian-vs-Asian
7.390000E-01
AfricanAmerican-vs-Asian
9.827000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.832600E-01
Normal-vs-Female
8.192200E-01
Male-vs-Female
4.991800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.711400E-01
Normal-vs-Age(41-60Yrs)
7.641400E-01
Normal-vs-Age(61-80Yrs)
7.989800E-01
Normal-vs-Age(81-100Yrs)
6.454200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.933030E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.216400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.413800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.920500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.733640E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.118200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.251800E-01
Normal-vs-Daily Drinker
5.489800E-01
Normal-vs-Weekly Drinker
9.175800E-01
Normal-vs-Occasional Drinker
6.526600E-01
Normal-vs-Social Drinker
8.650800E-01
Non Drinker-vs-Daily Drinker
8.480600E-01
Non Drinker-vs-Weekly Drinker
4.354400E-01
Non Drinker-vs-Occasional Drinker
7.061600E-02
Non Drinker-vs-Social Drinker
6.410000E-01
Daily Drinker-vs-Weekly Drinker
4.303800E-01
Daily Drinker-vs-Occasional Drinker
5.782200E-02
Daily Drinker-vs-Social Drinker
5.569600E-01
Weekly Drinker-vs-Occasional Drinker
3.296200E-01
Weekly Drinker-vs-Social Drinker
8.919800E-01
Occasional Drinker-vs-Social Drinker
2.819000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.272200E-01
Normal-vs-Grade 2
1.540310E-02
Normal-vs-Grade 3
3.483800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.163050E-03
Grade 1-vs-Grade 3
1.835760E-03
Grade 1-vs-Grade 4
1.272200E-01
Grade 2-vs-Grade 3
3.979600E-01
Grade 2-vs-Grade 4
1.540310E-02
Grade 3-vs-Grade 4
3.483800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.823600E-01
Normal-vs-NonDiabetic
8.438200E-01
Diabetic-vs-NonDiabetic
7.390600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.314400E-01
Normal-vs-NoPancreatitis
8.846800E-01
Pancreatitis-vs-NoPancreatitis
1.800390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.853000E-01
Normal-vs-N1
9.590000E-01
N0-vs-N1
1.051360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.368600E-01
Normal-vs-TP53-NonMutant
4.634800E-01
TP53-Mutant-vs-TP53-NonMutant
2.154800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
